Company profile for Appili Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Appili Therapeutics Inc., was founded in 2015 by a team of drug development, infectious disease, and commercialization experts to advance the global fight against infectious disease and the mounting threat of drug-resistant pathogens. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives....
Appili Therapeutics Inc., was founded in 2015 by a team of drug development, infectious disease, and commercialization experts to advance the global fight against infectious disease and the mounting threat of drug-resistant pathogens. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives. Appili cultivates a culture of listening: to the needs of patients, healthcare practitioners, researchers, employees, and shareholders.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
#21-1344 Summer Street Halifax, NS B3H 0A8
Telephone
Telephone
902-442-4655
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/13/3187940/0/en/Appili-Therapeutics-Reports-Financial-and-Operational-Results-for-Second-Quarter-of-Fiscal-Year-2026.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181334/0/en/Appili-Therapeutics-Announces-Proposed-Non-Brokered-Private-Placement.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/22/3170974/0/en/Appili-Therapeutics-to-Attend-BARDA-Innovation-Symposium-2025.html

GLOBENEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/01/3159377/0/en/Appili-Therapeutics-and-its-Partner-Vitalex-Biosciences-Awarded-Contract-from-NIAID-Valued-at-up-to-US-40-Million-to-Develop-Fungal-Vaccine-VXV-01.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/09/23/3155118/0/en/Appili-Therapeutics-Announces-Results-of-Annual-and-Special-Meeting-of-Shareholders.html

GLOBENEWSWIRE
23 Sep 2025

https://www.globenewswire.com/news-release/2025/09/09/3146770/0/en/Appili-Therapeutics-to-Present-Progress-on-Tularemia-Biodefense-Vaccine-at-NATO-CBRN-Conference.html

GLOBENEWSWIRE
09 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty